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Introduction: Children younger than 2 years have an increased risk of complications
associated with tuberculosis (TB) due to the immaturity of the innate and adaptive
immune response. We aimed to identify TB clinical presentations and outcomes as well
as risk factors for complications in this age group.
Materials and Methods: Multicenter, retrospective, cross-sectional study of TB cases
in children aged <2 years in Catalonia (2005–2013). Epidemiological and clinical data
were collected from the hospital medical records. TB complications, sequelae included,
were defined as any tissue damage generating functional or anatomical impairment
after being diagnosed or after TB treatment being completed. Statistical analyses were
based on bivariate chi-square and multivariate logistic regression, and it was carried
out with Stata® version 13.1. Odds ratios (OR) and its 95% confidence intervals were
calculated (CI).
Results: A total of 134 patients were included, 50.7% were male, the median [IQR]
age was 13[8-18] months, and 18.7% (25/134) showed TB-associated complications.
Pulmonary TB was diagnosed in 94.0% (126/134) of children, and the most
common complications were lobar collapse (6/126). TB meningitis was diagnosed
in 14/134 (10.4%), and hydrocephalus and mental impairment occurred in 1 and 2
patients, respectively. Two patients with spinal TB developed vertebral destruction and
paraplegia, respectively. Only one of the patients died. At multivariate level, tachypnea
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(OR = 4.24; 95% CI 1.17–15.35) and meningeal (OR = 52.21; 95% CI 10.05–271.2) or
combined/extrapulmonary forms (OR = 11.3; 95% CI 2.85–45.1) were associated with
the development of TB complications.
Discussion: TB complications are common in children under 2 years old.
Extrapulmonary TB forms in this pediatric age remain a challenge and require prompt
diagnosis and treatment in order to prevent them. The presence of tachypnea at
the time of TB diagnosis is an independent associated factor to the development of
TB complications in infants. This clinical sign should be closely monitored in patients
in this age group. It is necessary to perform further studies in this age group in a
prospective design in order to understand whether there are other factors associated
to TB complications.
Keywords: tuberculosis, infants, low-incidence country, complications, sequelae, risk factors
INTRODUCTION
An estimated one million children were diagnosed with
tuberculosis (TB) in 2016, according to World Health
Organization (WHO) data (1). In the European WHO region,
the European Centre for Disease Prevention and Control
(ECDC) estimated that Spain, the United Kingdom, Romania,
and France contributed 62% of pediatric TB cases occurring in
the European Union/European Economic Area countries (2).
However, the true global incidence and prevalence of
childhood TB remains uncertain due to lack of microbiological
confirmation of active TB in the majority of children (3).
Children typically have a paucibacillary disease, which hinders
the detection of Mycobacterium tuberculosis in biological
samples. Also, respiratory specimens (i.e., sputum) are difficult
to obtain in young children and, consequently most children
with active TB worldwide are started on treatment based solely
on clinical history, clinical symptoms, and radiological signs
(3). Microscopic examination of sputum smears is the key to
diagnosis in most countries, but its usefulness is limited in
young children with paucibacillary disease who are also unable
to expectorate (4).
Children in whom M. tuberculosis infection is detected,
young children and those with recent exposure are at increased
risk for progression to disease (4). Knowledge of the child’s
status regarding exposure intensity to the index case modifies
the pre-test probability of disease and the positive predictive
value of subsequent investigations (4). In fact, children under
two account for the major part of the elevated morbidity and
mortality associated with TB (5). Moreover, the diversity of
the clinical presentation in infants and young children and the
non-specific nature of most signs and symptoms complicate TB
diagnosis at this age. Constitutional symptoms often include
failure to thrive and reduced playfulness (4). Non-specific
clinical manifestations, particularly in meningeal forms, further
complicate early recognition of the disease in these infants (6, 7).
Finally, the recognition of cellular immune response against
M. tuberculosis is based on two main tests, the tuberculin skin
test (TST) and the interferon-γ release assays (IGRAs). However,
these tests fail to differentiate M. tuberculosis infection from
active disease, and their sensitivity is lower in this age group than
in older children, making it more difficult to establish diagnosis
of infection (4). The contribution of all these factors leads to delay
in diagnosis that can be crucial for the patient’s clinical outcome
and complication occurrence (6, 7).
Literature is scarce on treatment outcome, complications and
sequelae occurring in TB diagnosed in children under two.
Wiseman et al. (6) described complications as any infiltration
or compression of anatomical structures adjacent to the affected
site (i.e., neurologic, vascular, bronchial, cardiac, and bone
complications), with the potential to cause a functional deficit.
The aims of this study were: 1/ to determine the prevalence
rate of TB clinical presentations, outcomes and complications
occurring in a large cohort of children with TB under
two, and 2/ to investigate the factors associated with these
complications. Knowledge of these factors will help in applying
preventive measures.
MATERIALS AND METHODS
Design and Setting
This was amulticentric cross-sectional study of pediatric TB cases
diagnosed in children under 2 years of age from January 2005
to December 2013 in 10 hospitals which are part of the public
Healthcare Network of Catalonia, Spain.
During 2013, the last year of our period of inclusion in the
study, a total of 1,135 TB cases were registered in Catalonia,
which represents a rate of 15.1 cases per 100,000 population;
pediatric patients, aged under 15 years old accounted for 8.5% of
the total1. In Barcelona, capital city of Catalonia, 1.2% (92 cases)
of the total TB registered during the period of 2000-2017 affected
children under 2 years of age, and incidence of TB showed a
progressive and declining trend from 45 to 11 cases per 100,000
population (Dr. A Orcau, TB Control Program Barcelona—as yet
unpublished data).
Data were retrospectively collected from the patient’s medical
history at the time of TB diagnosis (in hospital or healthcare
1http://salutpublica.gencat.cat/ca/detalls/Article/Publicacio-informe-TBC-2015
(accessed September 13, 2018).
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center). Data related to subsequent clinical evolution at follow-
up visits in the Primary Healthcare Centers was collected through
the ECAP system (“Estació clínica d’atenció primària”), which
is the computerized clinical history used by all professionals in
the primary care network of Catalonia, and the shared clinical
history of Catalonia. Any health professional working in any
of the Catalonian health-care centers can obtain information
on patient follow-up regardless of contact with the hospital
where the patient was diagnosed or treated for TB. Patients were
identified at each center by the local participating physician and
monitored at least until the end of TB treatment. They were
also monitored until the end of 2015 through data obtained
from patients’ clinical records. Data were collected at the time
of TB diagnosis, at completion of TB treatment again, and at
completion of follow-up procedure (December 31, 2015).
Variables
Demographical, epidemiological, and clinical data was collected.
Variables collected for the study were the following:
Demographical: Sex, date of birth, country of birth, and date
of arrival to Europe in the case of immigrant children.
Epidemiological: Household with TB cases, Bacillus Calmette-
Guérin (BCG) vaccination, contact tracing, and resistance test for
the index case.
Clinical: Duration of symptoms prior to diagnosis, poor
weight gain, respiratory distress, tachypnea, intensive
care admission, fever, hepatomegaly, splenomegaly, poor
nutrition, irritability, neurological symptoms, lymph nodes,
gastrointestinal symptoms, and vomiting.
Complementary exams: Chest X-ray (CXR), chest computed
tomography (CT), human immunodeficiency virus (HIV) test,
clinical TB form, microbiological diagnosis, diagnostic tests for
microbiological diagnosis, and tuberculin skin test (TST or
Mantoux test).
Treatment: type of TB treatment and date commenced, length
of therapy (months), and completion of treatment.
Outcome: Complications secondary to TB (yes/no), and site
of complications.
Definitions
- Case of tuberculosis was defined as patient meeting following
two criteria: (1) Presence of clinical or radiological signs
and/or symptoms compatible with TB disease of any location,
as long as there is no evidence of another disease to explain
their existence. (2) Prescription of standard anti-tuberculosis
treatment, generally using three or more drugs. This definition
includes confirmed and suspected cases (8, 9).
- TB complication was defined as any tissue injury leading
to functional or anatomical impairment after completion of
TB treatment or after TB diagnosis (7). TB sequelae were
also included as a specific type of complication and defined
as any anatomic lesion produced and maintained during a
long-term period (at least 2 years) after completion of TB
treatment. This includes cavitation, focal secondary fibrosis,
bronchiectasis, starchy or linear fibrous healing of a cured
cavity, destroyed lung on finalizing treatment, airway lesions
including bronchiectasis, bronchial stenosis, and even tracheal
deformities; In the vascular system: bronchial arteritis,
thrombosis, bronchial artery dilatations, aneurysms of the
bronchial arteries, pulmonary hypertension compromise
secondary to destruction of the pulmonary vascular bed
and chronic pulmonary heart; mediastinal lesions, with
displacement, mediastinal fibrosis, hilar, and mediastinal
lymph node calcifications, esophageal fistulas, chronic
pneumothorax, with or without fluid effusion; and lesions
of the thoracic walls, with costal retractions or alterations
produced by surgical procedures (10). TB meningitis
complications were included when any of the following
was present: tuberculoma, cavernous sinus syndrome,
cranial nerve palsy, stroke, cerebral edema/hydrocephalus,
mental impairment/memory loss, spinal involvement,
audiologic/visual impairment, epilepsy, and hypothalamic
syndrome (11).
- Low weight gain was defined as the inability to maintain an
adequate weight curve, established by a percentile drop during
the period prior to TB diagnosis on standardized age and sex
chart (12).
- Tachypnea was defined according to WHO (13) as following:
respiratory rate (RR) of > 60 per minute in children under
2 months, > 50 per minute in children between 2 and
12 months, and > 40 per minute in children older than
12 months.
- Household contact: when the index case lives in the same
flat/apartment/house as diagnosed child.
- TST was used to screen the subject under study with bacillary
antigens, which causes a delayed cellular immune response in
the infected individual. We used a dose of 2UT (0.1ml) of
PPD RT 23 with Tween 80. The injection was given on the
inside forearm, and the test reading was carried out within 48–
72 h. The transverse diameter of the induration produced in
the infected children marked the result of this test measured
in millimeters.
Analysis
A descriptive analysis of the variables was carried out. Categorical
variables were expressed in number and percentage. Continuous
variables were expressed as the median and interquartile range
(IQR). The distribution of the main variable was compared with
the remaining variables using the Fisher exact test (dichotomous
variables) or Mann-Whitney U-test (continuous variables).
Comparison between patients with and without complications
took place. At the bivariate level, associations were examined
using the odds ratio (OR) with its 95% confidence interval (CI).
The associated variables were analyzed at the multivariate level
by logistic regression following the Bayesian multiple imputation
methods. Significance was set at a p-value of ≤ 0.05. The
statistical analysis was performed with the Stata R© (version 13.1)
software package (College Station, Texas, USA).
Ethics
Confidentiality of data was maintained at all times in
accordance with the guidelines of Organic Law 15/1999
(Ley Orgánica 15/1999), “Protection of Personal Data.”
This study was evaluated and approved by the Clinical
Research Ethics Committee of the Hospital Universitari
Vall d’Hebron (CEIC—HUVH, project PR(AMI)349/2015),
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as the coordination center. In order to participate each
center obtained approval from the corresponding Ethics
Committee. As this was a retrospective study that did not
involve interventions other than usual clinical practice and
in accordance with national legislation informed consent was
not required.
RESULTS
A total of 134 patients was included and follow-up information
was collected until the end of 2015. The median duration
of follow-up was 86 months (range: 61–106 months).
Epidemiological and microbiological characteristics of the
study are described in Table 1. It was relevant that almost all of
them were Spanish-born, had a positive TST and the CXR or
thoracic CT were compatible with TB. Regarding CT, the test
was performed in 63 children, of which: 59 were compatible with
TB, 2 abnormal but unlikely TB and 2 were normal. All patients
except one completed TB treatment, and the BCG vaccination
coverage was low. Most of the children had an active TB case at
home (household adult TB contact). The cases in which there
were other TB cases in the home hadmore exclusively pulmonary
forms than those with no active TB cases in the home (p= 0.03).
Moreover, those with no TB cases in the home were older (>12
months of age: 73.9 vs. 45.3% p-value = 0.002), presented more
symptoms before diagnosis (87 vs. 44% p-value < 0.001) and
suffered more TB related complications (32.6 vs. 10.7% p-value=
0.003). Microbiological investigation was performed in 110/134
(82.1%) of the TB cases. Throughout all TB cases included in
the study, less than one third were confirmed by microbiology
diagnostic tests (44/134), 4/106 (3.8%) by acid-fast bacilli (AFB)
strain, 13/47 (27.7%) by GenXpert R©MTB/RIF (Cepheid R©) and
27/110 (24.5%) by culture. Among those with microbiological
study, 44/110 (40%) were confirmed with any of the tests (AFB
or GenXpert R©MTB/RIF or culture). Two cases of multi-drug
resistance TB (MDR-TB) were detected. None of the children
tested positive for HIV co-infection. One patient died (case
fatality rate of 0.7%) due to neurological complications after
TB meningitis.
Table 2 shows a description of all TB-related clinical
manifestations of study subjects. Over one-third of the children
were asymptomatic (37.3%; 50/134) at the moment of TB
diagnosis. In pulmonary TB, this percentage was even higher
representing nearly half the cases. On the contrary, cases of TB
meningitis were almost uniformly symptomatic on TB diagnosis.
The most common clinical signs and symptoms on diagnosis
were fever >38◦C, tachypnea, poor feeding, poor weight gain,
and irritability.
Pulmonary TB was themost common clinical form, but nearly
20% of the cases (25/126) had other organ or system involvement.
The most frequent extrapulmonary TB cases were meningeal,
lymphatic, pleural, miliary, osseous, and genitourinary (Table 3).
Among the 14 cases with TB meningitis, 12 were investigated
using AFB stain, GenXpert R©, and culture, and 2 using
only AFB stain and culture. Ten (71.4%) of them were
microbiologically confirmed.
TABLE 1 | Epidemiological and clinical characteristics of 134 children with
tuberculosis under 2 years old during the 2005-2013 period in Catalonia.
Variable Frequency/total
TB cases (%)
Frequency/only
pulmonary TB cases (%)
Female 66/134 (49.3) 48/101 (47.5)
Age in months (median, IQR) 13 (8–18) 13 (9–18)
Age 0–12 months 56/134 (41.8) 42/101 (41.6)
Spanish born 127/134 (94.8) 94/101 (93.1)
Country of exposition (VFR) 10/134 (7.5) 4/101 (4.0)
BCG vaccination 3/134 (2.2) 3/101 (3.0)
TST positive 122/134 (91.0) 94/101 (93.1)
Chest XR or CT consistent with TB 113/134 (84.3) 89/101 (88.1)
Microbiological confirmation 44/134 (32.8) 27/101 (26.7)
DST of index case (known) 60/134 (44.8) 47/101 (46.5)
Sensitive to first line drugs 58/60 (96.7) 47/47 (100.0)
MDR-TB 2/60 (3.3) 0/47 (0.0)
Contact investigation completed 98/130 (75.4) 79/98 (80.6)
Active TB case at home* 75/121 (62.0) 62/92 (67.4)
Treatment completion 132/133 (99.3) 100/100 (100.0)
TB, tuberculosis; IQR, interquartile range; VFR, visiting friends and relatives; BCG, bacillus
Calmette-Guérin vaccine; TST, tuberculin skin test; XR, X-ray; CT, computed tomography;
MDR-TB, multi-drug resistant tuberculosis; DST, drug susceptibility testing.
* It is statistically significant the association between the presence of active TB case at
home and the exclusively pulmonary TB forms (p = 0.03), the younger age (p = 0.002),
less symptomatology (p < 0.001), and less TB related complications (p = 0.003) when
compared to the cases with no active TB case at home.
Concerning TB-associated complications (Table 4), 18.7% of
the children had complications, but the highest percentage was
among TB meningitis cases followed by other TB cases and
pulmonary TB cases. Lung lobar collapse was the most common
pulmonary TB-related complication among the pulmonary TB
forms but also among all the TB cases. Bronchospasm was
considered a TB related complication as the episodes of wheezing
were temporarily correlated after TB diagnosis and none of
them had experienced any prior bronchiolitis or wheezing.
No paradoxical reactions have been reported among the 134
TB cases.
At the bivariate analysis level, to be symptomatic at diagnosis,
having extrapulmonary TB, including meningeal and mixed
forms, and tachypnea and fever >38◦C at diagnosis were
associated with the development of TB complications (see
Table 5). In contrast, to have a household TB contact was a
protective factor for TB complications.
In the multivariate analysis, only extrapulmonary and
combined clinical TB forms, and the presence of tachypnea
at diagnosis remained risk factors for the development of
TB complications.
In the case of children suffering pulmonary TB, tachypnea
was found to be associated with complications in the bivariate
analysis (Table 6).
DISCUSSION
The presence of TB complications in this study carried out in
children under two in a low incidence country was relevant,
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TABLE 2 | Clinical characteristics at tuberculosis diagnosis in 134 children under 2 years old during the 2005-2013 period in Catalonia according to the clinical form.
Variable Pulmonary TB (N = 101) TB meningitis (N = 14) Total TB (N = 134)
N (%) N (%) N (%)
Clinical manifestations (signs or symptoms) 56 55.4 13 92.9 84 62.7
Symptoms duration
< 2 weeks
39 38.6 9 64.3 58 43.3
Duration
> 2 weeks
17 16.8 4 28.6 26 19.4
Respiratory distress 6 5.9 3 21.4 12 9.0
Tachypnea 30 29.7 6 42.9 41 30.6
Fever > 38◦C 39 38.6 9 64.3 56 41.8
Poor feeding 9 8.9 3 21.4 16 11.9
Poor weight gain 7 6.9 3 21.4 13 9.7
Intensive care admission required 0 0.0 6 42.9 6 4.5
Hepatomegaly 3 3.0 1 7.1 6 4.5
Splenomegaly 0 0.0 1 7.1 3 2.2
Irritability 6 5.9 7 41.2 13 9.7
Neurological signs 0 0.0 6 42.9 7 5.2
Lymph nodes palpable 2 2.0 1 7.1 9 6.7
Gastrointestinal symptoms (diarrhea, abdominal distention) 7 6.9 2 14.3 9 6.7
Vomiting 5 5.0 3 21.4 8 6.0
TB, tuberculosis.
TABLE 3 | Clinical forms of tuberculosis in 134 patients under 2 years old
according to lung involvement.
Clinical presentation Total
N∧ %
Pulmonary 126 94.0
Meningeal 14 10.4
Lymphatic 13 9.7
Pleural 4 3.0
Miliary 4 3.0
Osseous 2 1.5
Genitourinary 1 0.7
Exclusively Pulmonary 101 75.4
Combined (Pulmonary and extrapulmonary) 25 18.7
Exclusively extrapulmonary 8 6.0
∧The same TB case may be in more than one category depending on the affected organs.
Bold values include all TB cases categorized according to lung involvement. Values without
bold type classify cases based on the affected organ.
affecting nearly one in five of the cases studied. Risk factors for TB
complications at the time of TB diagnosis were extrapulmonary
or combined forms and tachypnea.
Although especially younger children are found to have more
illnesses, to develop TB easily and also suffer the most severe
forms of the disease, there is a lack of information regarding
the incidence of TB complications in this age range. In existing
scientific databases such as MEDLINE through PubMed R© free
search engine, most of the articles studying this issue are
limited to high-burden TB countries such as South Africa (14,
15), to specific clinical forms such as TB meningitis (16, 17),
or to reporting rare complications such as hypercalcemia as
an extrapulmonary TB complication (18). We found a study
undertaken among 80 children diagnosed with TB at a medical
center in southern Taiwan over a period of 24 years (1988–
2012) with a similar approach to our study (19). However, this
study, published in 2013, was also principally focused on central
nervous system (CNS) complications due to TB meningitis (19).
It would therefore be correct to say that factors related to TB
complications in children under 2 years old in country with
low-incidence TB remain a surprisingly under-studied aspect.
The World Health Organization estimated that more than
80% of TB cases in children under 14 are concentrated in 22
developing countries (1), mainly in Africa and South East Asia.
The difficulty of diagnosis, lack of resources for contact tracing
in many areas and limited pediatric surveillance data in TB
control programs (20) are some of the main reasons for lack of
knowledge on the real incidence of childhood TB worldwide and
subsequently to make an estimate of how many of these children
will develop TB complications after treatment.
Regarding the epidemiological characteristics of our sample
study, it is important to highlight that most of them were born in
Spain (94.8%). They were therefore infected in a low-incidence
TB environment; only 7.5% of them were exposed in high-
incidence TB countries overseas. The existence of a household
TB case was associated with pulmonary TB forms in children
when compared to disseminated, meningeal, or combined forms
(p= 0.03). This could be explained by earlier TB diagnosis when
children are included in the contact tracing study with the index
case in the same household. Consequently, delay in diagnosis
and development into more advanced forms of the disease tends
to diminish. Contact tracing investigation was completed in
75.4% of the cases, a higher percentage than that observed in
other studies in high-burden countries such as South Africa (14),
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TABLE 4 | Tuberculosis complications in 134 children under 2 years old during
the 2005–2013 period in Catalonia.
Variable Frequency/total TB
cases (%)
Frequency/only
pulmonary TB
cases (%)
Frequency/total TB
meningitis
cases (%)
Development of complications
Yes 25/134 (18.7) 7/101 (6.9) 11/14 (78.6)
No 109/134 (81.3) 94/101 (93.1) 3/14 (21.4)
Pulmonary
TB-related
complications
13/134 (9.7) 7/101 (6.9) 4/14 (28.6)
Bronchiectasis 1/13 (7.7) 0/7 (0.0) 1/4 (25.0)
Lobar collapse 6/13 (46.1) 6/7 (85.7) 3/4 (75.0)
Bronchial stenosis
(endobronchitis)
1/13 (7.7) 1/7 (14.3) 0/4 (0.0)
Episodes of
bronchospasm
5/13 (38.5) 0/7 (0.0) 0/4 (0.0)
Pleural TB-related
complications
2/134 (1.5)
Pleurisy* 2/2 (100.0)
Lymphatic
TB-related
complications
3/134 (2.2)
Ulceration 1/3 (33.3)
Cellulitis 1/3 (33.3)
Fistula 1/3 (33.3)
Meningeal
TB-related
complications
3/134 (2.2) 3/14 (21.4)
Hydrocephalus/
Brain oedema
1/3 (33.3) 1/3 (33.3)
Mental disability/
Psychomotor
retardation
2/3 (66.7) 2/3 (66.7)
Spinal TB-related
complications
2/134 (1.5) 1/14 (7.1)
Abscess/Vertebral
destruction
1/2 (50.0) 0/1 (0.0)
Paraplegia/
Tetraplegia
1/2 (50.0) 1/1 (100.0)
TB, tuberculosis.
*Pleural TB complications were those requiring surgical intervention secondary to pleural
TB as lesions of the thoracic walls with costal retractions or alterations produced by
surgical procedures.
and similar to that observed in Barcelona (21). Microbiological
confirmation was achieved in nearly one-third of the children
(32.8%), representing a higher percentage of confirmed TB cases
when compared to other studies also from South Africa (15),
Mozambique (22), or Ethiopia (23). The percentage of cases
with microbiological confirmation was limited, due to the lower
performance of microbiological studies in children, especially in
younger ones (3), and partly due to the fact that good contact
investigations are done which favor early diagnosis and avoid
advanced and complicated forms. Finally, the rate of treatment
completion was achieved in nearly 100% of our patients which is
remarkable data compared to other studies (15, 22).
Regarding clinical manifestations, our study shows great
differences as compared to adult TB symptomatology. Fever was
absent in most of the recruited children when taking into account
total TB cases but was more prevalent in meningeal than in
pulmonary cases. Respiratory distress including tachypnea was
also more frequent in TB meningitis cases than in pulmonary
forms, presumably due to the CNS involvement in disseminated
or meningeal TB.
In our study, 18.7% of the TB patients developed TB-
associated complications, and one of them died (0.7%).
Comparisons with other studies are difficult due to the lack
of published data. The highest percentage of TB complications
was observed among patients with TB meningitis, followed by
the combined forms. A slightly higher rate of TB complications
was observed in a study among Spanish children diagnosed
with pulmonary TB (24). Lobar collapse was the most frequent
complication in children under 2 with pulmonary TB. The
same was observed in another study where lung collapse might
occur secondary to an endobronchial obstruction or an extrinsic
compression caused by lymphadenopathy (24). In our study,
bronchiectasis was found in only one case; this was likely to have
been caused by fibrosis of the bronchial wall occurring during
disease or by traction resulting from areas of scar tissue (10).
Regarding bronchospasm, it was possible to temporarily correlate
the episodes of wheezing after TB diagnosis. However, we were
not able to demonstrate whether these episodes were caused
by TB.
The incidence of the pleural involvement varies considerably,
being much higher in high-incidence TB areas, affecting up to
40% of cases in South Africa (25). In Canada (26), a country
with a lower TB incidence than Spain, Pineda et al. (27) detected
pleural involvement in 4% of 202 patients with pulmonary TB,
whereas in our study, only 1.5% of children showed pleural TB
related complications.
Peripheral lymphadenopathy is the most common clinical
sign in infants diagnosed with TB, seen in 25–35% of
extrathoracic TB cases, according to daita from the Spanish
Society of Pediatric Infectious Diseases (28). In our study,
10 children (7.5%) had extrapulmonary TB complications—
three of them were lymphatic TB-related (cellulitis, fistula,
and ulceration)—accounting for 40% of all TB-complications.
The explanation for this could be due to the greater risk of
disseminated and combined forms in infants when compared to
older children or adults.
TB meningitis is the most severe and life-threatening form
of the disease in infants (29). Prompt diagnosis and treatment
is essential to the improvement in prognosis of the disease
by decreasing the case fatality rate (CFR) and the incidence
of irreversible complications (30). The main risk factors for
an unfavorable prognosis, including death, are a low Glasgow
Coma Scale value at diagnosis, and age under 2 (30). Ten
percent of our children had TB meningitis, much lower than
in the under 3-year-old age-group of the largest cohort of
culture-confirmed childhood TB from South Africa (14). In a
study on TB meningitis in Romania, complications affected 36
and 14% of children and adults, respectively (31); illustrating
the greater risk in children with this condition. Otherwise,
we found TB-complications in 78.6% of the cases of TB
meningitis in our study, among which 21.4% (3/14) were
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TABLE 5 | Factors associated with tuberculosis complications in a cohort of 134 children under 2 years old.
Variable N complications/total p-value cOR 95% CI p-value aOR 95% CI
Gender
Male 11/68 (16.2) 1
Female 14/66 (21.2) 0.45 1.4 0.58–3.34
Age
0–1 9/56 (16.1) 1
1–2 16/78 (20.5) 0.51 1.35 0.55–3.32
Low weight gain
No 20/118 (16.9) 1
Yes 5/13 (38.5) 0.07 3.06 0.91–10.34
Active TB case at home
No 15/46 (32.6) 1 1
Yes 8/75 (10.7) 0.004 0.25 0.09–0.64 0.18 0.44 0.13–1.45
Unknown 2/13 (15.4) 0.24 0.38 0.07–1.91 0.30 0.29 0.03–3.03
Country of exposition/VFR
No 22/124 (17.7) 1
Yes 3/10 (30.0) 0.35 1.99 0.48–8.29
Duration of clinical manifestations
0 (No clinical manifestations) 2/50 (4.0) 1
0–2 weeks 16/58 (27.6) 0.005 9.14 1.98–42.10
>2 weeks 7/26 (26.9) 0.01 8.84 1.68–46.45
TB Localization
Pulmonary only 7/101 (6.9) 1 1
Meningeal 11/14 (78.6) <0.001 49.24 11.10–218.42 <0.001 52.21 10.05–271.2
Extra or mixt 7/19 (36.8) 0.001 7.83 2.341–26.209 0.001 11.3 2.85–45.1
Microbiologic confirmation
No 13/90 (14.4) 1
Yes 12/44 (27.3) 0.07 2.22 0.91–5.39
Chest XR or CT
Done and normal 4/11 (36.4) 1
Changes compatible with TB 18/113 (15.9) 0.10 0.33 0.09–1.25
Abnormal but unlikely TB 3/10 (30.0) 0.76 0.75 0.12–4.66
Tachypnea
No 12/92 (13.0) 1 1
Yes 13/41 (31.7) 0.01 3.09 1.26–7.57 0.03 4.24 1.17–15.35
Fever > 38◦C
No 9/76 (11.8) 1
Yes 16/56 (28.6) 0.02 2.98 1.20–7.37
Poor feeding
No 19/114 (16.7) 1
Yes 5/16 (31.3) 0.17 2.27 0.71–7.29
Bivariate and multivariate analysis. cOR, crude Odds ratio; aOR, adjusted Odds ratio; CI, confidence interval; TB, tuberculosis; VFR, visiting friends and relatives; XR, X-ray; CT,
computed tomography.
related to CNS involvement, including psychomotor retardation
and hydrocephalus.
Lastly, musculoskeletal involvement has been described in 10–
20% of extrapulmonary TB cases, which would account for 1–2%
of all TB cases (32), data that is very similar to our results (25 and
1.5%, respectively).
Among all TB cases, at bivariate analysis, we found that
the presence of fever or tachypnea and the extrapulmonary
or combined forms were associated with TB complications.
Otherwise, as mentioned above, having a household TB contact
was a protective factor of these complications. At the multivariate
level, tachypnea and extrapulmonary or combined forms were
associated factors with TB complications. Nevertheless, when the
analysis was restricted to pulmonary TB cases, only tachypnea
was an associated factor in TB complications.
The fact that tachypnea at the time of TB diagnosis was an
independent variable associated to TB complications, could be
explained by the fact that it is a compensatory response secondary
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TABLE 6 | Presence of TB complications in a cohort of children under 2 years old
with pulmonary TB.
Variable N complications
/total
p-value cOR 95% CI
Gender
Male 3/53 (5.7) 1
Female 4/48 (8.3) 0.6 1.51 0.32–7.14
Age
0–1 1/42 (2.4) 1
1–2 6/59 (10.2) 0.16 4.64 0.54–40.08
Low weight gain
No 7/91 (7.7) 1
Yes 0/7 (0.0) 0.99 0
Active TB case at home
No 4/30 (13.3) 1
Yes 3/62 (4.8) 0.17 0.33 0.07–1.58
Unknown 0/9 (0.0) 0.99 0
Country of exposition/VFR
No 7/97 (7.2) 1
Yes 0/4 (0.0) 0.99 0
Duration of clinical manifestations
0 (No clinical manifestations) 1/45 (2.2) 1
0–2 weeks 5/39 (12.8) 0.09 6.47 0.72–58.00
>2 weeks 1/17 (5.9) 0.48 2.75 0.16–46.61
Microbiologic confirmation
No 7/74 (9.5) 1
Yes 0/27 (0.0) 0.99 0
Chest XR or CT
Changes compatible with TB 6/89 (6.7) 1
Abnormal but unlikely TB 1/7 (14.3) 0.47 2.31 0.24–22.39
Done and normal 0/5 (0.0) 0.99 0
Tachypnea
No 1/70 (1.4) 1
Yes 6/30 (20.0) 0.01 17.25 1.97–150.68
Fever > 38◦C
No 2/61 (3.3) 1
Yes 5/39 (12.8) 0.09 4.34 0.80–23.59
Poor feeding
No 7/89 (7.9) 1
Yes 0/9 (0.0) 0.99 0
cOR, crude Odds ratio; CI, confidence interval; TB, tuberculosis; VFR, visiting friends and
relatives; XR, X-ray; CT, computed tomography.
to hypoxemia for the small lung volume of restrictive lung disease
or metabolic acid mechanism of sis caused by advanced TB
disease. It is the earliest detectable clinical sign. Compensatory
mechanisms, such as tachypnea, also operate to maximize
gaseous exchange in diseased lungs (33). Moreover, tachypnea
is a useful sign for the diagnosis of childhood pneumonia. It is
more specific and reproducible than auscultatory signs (34) and
has been identified by the last British clinical updates for the
management of community-acquired pneumonia in children as
a sign of moderate or severe pneumonia in the risk assessment
algorithm (35). However, as a prognosis factor, tachypnea
has only been associated to worst outcome in adults with
community-acquired pneumonia (36), but not yet in children.
In contrast to the data from studies in areas with high
incidence of TB and HIV coinfection such as South Africa (CFR
21%) (37) or Myanmar (CFR 11.4%) (38), there was only one
death in our study representing a CFR of 0.7% over the total
TB cases. Other studies in Kenya (39) or among MDR TB
cases in children (40) showed CFR percentages of 4 and 21%,
respectively. Since this is a cross-sectional retrospective study,
the data collection process was subject to limitations, and the
possibility of missing information exists. It was difficult to obtain
long-term data since most of the patients were discharged from
the specialized medical unit at completion of treatment. Hence,
we cannot ensure that additional complications of the disease
did not develop at a later stage. The relatively high percentage of
TB meningitis (10.4%) in our sample might not be representative
of the childhood TB population, leading to selection bias due to
the hospital-based design of our study. However, this difference
was minimal if we take into consideration the data provided by
the TB Control Program of Barcelona / Public Health Agency
of Barcelona for this age-group of children with TB meningitis
during the 2000–2017 period (6.5%). Another limitation is that
we were able to determine if the children had complications
during and after TB treatment, but not when each of the events
occurred or how long it lasted. It is not possible to distinguish
between TB complications that lasted until the end of TB
treatment and long-lasting sequelae (maintained during at least
2 years after TB treatment completion).
In conclusion, our findings show that TB incidence in children
under 2-years of age is still relevant in developed countries, and
TB complications are frequent. Extrapulmonary TB forms in this
pediatric age remain a challenge and require prompt diagnosis
and treatment to prevent adverse outcomes. The presence of
tachypnea at the time of TB diagnosis is an independent
associated factor to the development of TB complications in
infants. Hence, this clinical sign should be closely monitored
in patients within this age group. It is necessary to perform
further studies in this group of children in a prospective study
designed to ascertain whether other factors associated with TB
complications exist.
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